Product NDC: | 63323-113 |
Proprietary Name: | Pentam 300 |
Non Proprietary Name: | PENTAMIDINE ISETHIONATE |
Active Ingredient(s): | 300 mg/3mL & nbsp; PENTAMIDINE ISETHIONATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-113 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019264 |
Marketing Category: | NDA |
Start Marketing Date: | 20010116 |
Package NDC: | 63323-113-10 |
Package Description: | 10 VIAL in 1 TRAY (63323-113-10) > 3 mL in 1 VIAL |
NDC Code | 63323-113-10 |
Proprietary Name | Pentam 300 |
Package Description | 10 VIAL in 1 TRAY (63323-113-10) > 3 mL in 1 VIAL |
Product NDC | 63323-113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PENTAMIDINE ISETHIONATE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20010116 |
Marketing Category Name | NDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | PENTAMIDINE ISETHIONATE |
Strength Number | 300 |
Strength Unit | mg/3mL |
Pharmaceutical Classes | Antiprotozoal [EPC] |